
Home
About/Contact
Newsletters
Events/Seminars
2020 IPS Conference
Study Materials
Corporate Members
Home
About/Contact
Newsletters
Events/Seminars
2020 IPS Conference
Study Materials
Corporate Members
The Soreq Applied Research Accelerator Facility, SARAF, is currently under construction at Soreq NRC. SARAF will be a multi-user facility for basic, medical and biological research, non-destructive testing (NDT) and research, development and production of radio-isotopes for pharmaceutical purposes. SARAF is based on a continuous wave (cw), proton/deuteron RF superconducting linear accelerator with variable energy (5-40 MeV) and current (0.04-2 mA). Phase I of SARAF has been installed and is currently being commissioned at Soreq NRC. According to the Phase I design, SARAF should yield 2 mA proton and deuteron beams at energies up to 4 and 5 MeV, respectively. The status of the main Phase I components is reported. We further present beam commissioning results, which include acceleration of a 1 mA CW proton beam up to 3 MeV. Further improvements in the facility in order to achieve the desired performance are discussed.